Sabra Health Care REIT, Inc. Financials

Market Capitalization $4.43 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	31.02
Forward PE	27.38
Price to Sales TTM	$6.15
Price to Book MRQ	$1.64
Enterprise to Revenue	9.37
Enterprise to EBITDA	15.63

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	19.54%
Operating Margin	36.88%
Return on Assets TTM	3.14%
Return on Equity TTM	5.15%

Income Statement

Revenue TTM	$720,246,976
Revenue per Share TTM	$3.06
Quarterly Revenue Growth	10.60%
Gross Profit TTM	$487,825,984
EBITDA	$439,134,000
Net Income to Common TTM	$140,762,000
Diluted EPS TTM	$0.60
Quarterly Earnings Growth YoY	53.50%

Balance Sheet

Total Cash MRQ	$37,893,000
Total Cash per Share MRQ	$0.16
Total Debt MRQ	$
Total Debt to Equity MRQ	88.89
Current Ratio MRQ	0.85
Book Value per Share MRQ	$11.36

Cash Flow

Operating Cash Flow TTM	$338,008,992
Levered Free Cash Flow TTM	$271,172,736

SBRA Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	237,586,882
Float Shares	234,069,993
Avg 10 Volume	2,407,540
Avg 30 Volume	None
Shares Short	19,510,458
Short Ratio	7.29
Short % of Shares	11.58%
% Held by Insiders	1.28%
% Held by Institutions	99.49%

Stock Price Summary

Beta	0.81
Fifty Two Week Low	$15.11
Fifty Two Week High	$20.03
Fifty Two Week Change	17.30%
Day 50 MA	$17.88
Day 200 MA	$17.71

Dividends and Splits

Forward Annual Dividend Rate	$1.20
Forward Annual Dividend Yield	6.45%
Trailing Annual Dividend Rate	$1.20
Trailing Annual Dividend Yield	6.45%
Payout Ratio	200.00%
Dividend Date	2025-05-30
Ex Dividend Date	2025-05-16
Last Split Factor
Last Split Date	2010-11-16